MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PCSA has $7,813,567 in assets. $2,236,253 in debts. $5,536,955 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
253.59%
Quick Ratio
253.59%
Cash Ratio
247.60%
Debt to Asset Ratio
28.62%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Digital assets at fair value
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
5,536,955
Prepaid expenses and other
133,919
Total current assets
5,670,874
Digital assets at fair value
1,145,180
Prepaid expenses
993,701
Equipment, net
3,812
Total assets
7,813,567
Accounts payable
1,056,796
Accrued expenses
1,179,457
Total current liabilities
2,236,253
Total liabilities
2,236,253
Common stock, par value 0.0001, 1,000,000,000 shares authorized 2,572,114 issued and 2,571,914 outstanding at december 31, 2025 and 148,308 issued and 148,108 outstanding at december 31, 2024
257
Additional paid-in capital
106,660,090
Treasury stock, 200 shares at cost
300,000
Accumulated deficit
-100,783,033
Total stockholders equity
5,577,314
Total liabilities and stockholders equity
7,813,567
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$5,536,955 Prepaid expenses andother$133,919 Total current assets$5,670,874 Digital assets at fairvalue$1,145,180 Prepaid expenses$993,701 Equipment, net$3,812 Total assets$7,813,567 Total liabilities andstockholders equity$7,813,567 Total stockholdersequity$5,577,314 Total liabilities$2,236,253 Accumulated deficit-$100,783,033 Treasury stock, 200shares at cost$300,000 Additional paid-in capital$106,660,090 Total currentliabilities$2,236,253 Common stock, par value0.0001, 1,000,000,000...$257 Accrued expenses$1,179,457 Accounts payable$1,056,796

Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals, Inc. (PCSA)